Defective removal of invariant chain peptides from MHC class II suppresses tumor antigen presentation and promotes tumor growth

Summary: Tumor-draining lymph node dendritic cells (DCs) are poor stimulators of tumor antigen-specific CD4 T cells; however, the mechanism behind this defect is unclear. We now show that, in tumor-draining lymph node DCs, a large proportion of major histocompatibility complex class II (MHC-II) mole...

Full description

Saved in:
Bibliographic Details
Main Authors: Joanna Bandola-Simon, Yoshinaga Ito, Kai W. Wucherpfennig, Paul A. Roche
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Cell Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2211124724015018
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841560555728404480
author Joanna Bandola-Simon
Yoshinaga Ito
Kai W. Wucherpfennig
Paul A. Roche
author_facet Joanna Bandola-Simon
Yoshinaga Ito
Kai W. Wucherpfennig
Paul A. Roche
author_sort Joanna Bandola-Simon
collection DOAJ
description Summary: Tumor-draining lymph node dendritic cells (DCs) are poor stimulators of tumor antigen-specific CD4 T cells; however, the mechanism behind this defect is unclear. We now show that, in tumor-draining lymph node DCs, a large proportion of major histocompatibility complex class II (MHC-II) molecules retains the class II-associated invariant chain peptide (CLIP) fragment of the invariant chain bound to the MHC-II peptide binding groove due to reduced expression of the peptide editor H2-M and enhanced activity of the CLIP-generating proteinase cathepsin S. The net effect of this is that MHC-II molecules are unable to efficiently bind antigenic peptides. DCs in mice expressing a mutation in the invariant chain sequence that results in enhanced MHC-II-CLIP accumulation are poor stimulators of CD4 T cells and have diminished anti-tumor responses. Our data reveal a previously unknown mechanism of immune evasion in which enhanced expression of MHC-II-CLIP complexes on tumor-draining lymph node DCs limits MHC-II availability for tumor peptides.
format Article
id doaj-art-5b3d5cc680da42d1b81317af8f7040e5
institution Kabale University
issn 2211-1247
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Cell Reports
spelling doaj-art-5b3d5cc680da42d1b81317af8f7040e52025-01-04T04:56:17ZengElsevierCell Reports2211-12472025-01-01441115150Defective removal of invariant chain peptides from MHC class II suppresses tumor antigen presentation and promotes tumor growthJoanna Bandola-Simon0Yoshinaga Ito1Kai W. Wucherpfennig2Paul A. Roche3Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USAInstitute for Life and Medical Sciences, Kyoto University, Kyoto 606-8507, JapanDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA; Department of Neurology, Brigham & Women’s Hospital and Harvard Medical School, Boston, MA 02115, USAExperimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA; Corresponding authorSummary: Tumor-draining lymph node dendritic cells (DCs) are poor stimulators of tumor antigen-specific CD4 T cells; however, the mechanism behind this defect is unclear. We now show that, in tumor-draining lymph node DCs, a large proportion of major histocompatibility complex class II (MHC-II) molecules retains the class II-associated invariant chain peptide (CLIP) fragment of the invariant chain bound to the MHC-II peptide binding groove due to reduced expression of the peptide editor H2-M and enhanced activity of the CLIP-generating proteinase cathepsin S. The net effect of this is that MHC-II molecules are unable to efficiently bind antigenic peptides. DCs in mice expressing a mutation in the invariant chain sequence that results in enhanced MHC-II-CLIP accumulation are poor stimulators of CD4 T cells and have diminished anti-tumor responses. Our data reveal a previously unknown mechanism of immune evasion in which enhanced expression of MHC-II-CLIP complexes on tumor-draining lymph node DCs limits MHC-II availability for tumor peptides.http://www.sciencedirect.com/science/article/pii/S2211124724015018CP: ImmunologyCP: Cancer
spellingShingle Joanna Bandola-Simon
Yoshinaga Ito
Kai W. Wucherpfennig
Paul A. Roche
Defective removal of invariant chain peptides from MHC class II suppresses tumor antigen presentation and promotes tumor growth
Cell Reports
CP: Immunology
CP: Cancer
title Defective removal of invariant chain peptides from MHC class II suppresses tumor antigen presentation and promotes tumor growth
title_full Defective removal of invariant chain peptides from MHC class II suppresses tumor antigen presentation and promotes tumor growth
title_fullStr Defective removal of invariant chain peptides from MHC class II suppresses tumor antigen presentation and promotes tumor growth
title_full_unstemmed Defective removal of invariant chain peptides from MHC class II suppresses tumor antigen presentation and promotes tumor growth
title_short Defective removal of invariant chain peptides from MHC class II suppresses tumor antigen presentation and promotes tumor growth
title_sort defective removal of invariant chain peptides from mhc class ii suppresses tumor antigen presentation and promotes tumor growth
topic CP: Immunology
CP: Cancer
url http://www.sciencedirect.com/science/article/pii/S2211124724015018
work_keys_str_mv AT joannabandolasimon defectiveremovalofinvariantchainpeptidesfrommhcclassiisuppressestumorantigenpresentationandpromotestumorgrowth
AT yoshinagaito defectiveremovalofinvariantchainpeptidesfrommhcclassiisuppressestumorantigenpresentationandpromotestumorgrowth
AT kaiwwucherpfennig defectiveremovalofinvariantchainpeptidesfrommhcclassiisuppressestumorantigenpresentationandpromotestumorgrowth
AT paularoche defectiveremovalofinvariantchainpeptidesfrommhcclassiisuppressestumorantigenpresentationandpromotestumorgrowth